Improving DNA Sequencing
SLU ID 19-028 | Target Enrichment by Enzyme Digestion
Intellectual Property Status
Seeking
Provisional patent application filed
Know-how based
Licensee
Development partner
Commercial partner
Investment
University spin out
Background
Next-generation sequencing (NGS) is a common method in biomedical research and clinical medicine. When sequencing an explicit target with a small percent volume (e.g., HIV in patient blood samples), NGS suffers from a significant shortcoming. Current target enrichment and capture sequencing processes are costly, tedious, and sometimes insufficient due to off-target effects. A current need in the industry is for a simplified process that minimizes these off-target effects.
Overview
Researchers at Saint Louis University have created a novel process for target enrichment utilizing enzyme digestion that simplifies the sequencing process and minimizes off-target effects and contamination.
Benefits
The potential benefits of this technology include:
Minimizing the cost of sequencing DNA and RNA
Increasing process efficiency when sequencing DNA and RNA
Minimizing the tediousness of sequencing DNA and RNA
Minimizing the number of process steps required to sequence DNA and RNA
Minimizing off-target effects when sequencing DNA and RNA
Minimizing contamination when sequencing DNA and RNA
Increasing sensitivity of NGS methods
Applications
Potential applications of this technology include:
Sequencing DNA
Sequencing RNA
Next generation sequencing
High throughput sequencing
Opportunity
Saint Louis University is seeking partners to further develop and commercialize this technology.